Retroclavicular Versus Costoclavicular Approach for Infraclavicular Brachial Plexus Block

June 15, 2017 updated by: Antalya Training and Research Hospital

A Randomized Controlled Trial Comparing Retroclavicular and Costoclavicular Approach for Infraclavicular Brachial Plexus Block

The primary aim of this study is to compare needle shaft visibility between the retroclavicular approach and costoclavicular approach for infraclavicular brachial plexus block in patients undergoing elective upper limb surgery. Secondary aim is to investigate the differences between the two groups in sensorial block success rate, block performance time, block performance related pain, motor block success rate, surgical success rate, complications, patient satisfaction, use of supplemental local anesthetic, use of analgesic.

Study Overview

Detailed Description

Infraclavicular blocks are performed with different approaches. This study evaluated the effectiveness, safety and feasibility of a retroclavicular brachial plexus block as compared with costoclavicular approach for infraclavicular brachial plexus block. 60 patients scheduled for elective upper limb surgery were recruited and randomized into two groups: Retroclavicular approach for infraclavicular block (Group I), costoclavicular approach for infraclavicular block (Group R). Sensory block, adverse effects and complications were evaluated and recorded every 5 minutes until 30 min after local anesthetic injection. Success rate of each nerve sensory block, complications, rate of satisfaction, rate of failure and incidence rate of adverse effects, the needle shaft visibility, procedure time,duration of the block's effect, use of supplemental local anesthetic, use of analgesic are compared with both groups.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Antalya, Turkey, 07100
        • Antalya Training and Research Hospital, Department of Anesthesiology and Reanimation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 68 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients who undergo elective forearm or hand surgery under infraclavicular brachial plexus block
  • American Society of Anesthesiologists class 1 to 3
  • Ability to consent

Exclusion Criteria:

  • History of allergic reaction to local anaesthetics
  • Peripheral neuropathy
  • Renal or hepatic insufficiency
  • Coagulation disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: retroclavicular approach
Patients in this group will be randomized to receive an retroclavicular approach to Ultrasound Guided Infraclavicular Brachial Plexus Nerve Block .
Retroclavicular approach for ultrasound guided infraclavicular brachial plexus block
Active Comparator: costoclavicular approach
Patients in this group will be randomized to receive an costoclavicular approach to Ultrasound Guided Infraclavicular Brachial Plexus Nerve Block .
costoclavicular approach for ultrasound guided infraclavicular brachial plexus block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Needle shaft visibility
Time Frame: 10 minutes after the needle inserted the skin
Needle visibility reviewed by two anesthesiologists using a 5-point Likert scale
10 minutes after the needle inserted the skin

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Technique duration
Time Frame: Time required in seconds for the block completion (10 minutes)
Number of seconds needed to complete the block, from time of local skin anesthesia until regional block needle removal.
Time required in seconds for the block completion (10 minutes)
Patient satisfaction using a visual analogue scale
Time Frame: Assessed 24 hours after the block
Using a visual analog scala, patients will quantify their satisfaction with the retroclavicular and costaclavicular technique .
Assessed 24 hours after the block
supplemental analgesic used
Time Frame: 90 minutes after block completion
The use of supplementary local anesthetic and the use of intravenous narcotics were recorded.
90 minutes after block completion
complications such as pneumothorax, hemothorax, intraarterial injection, intravenous injection
Time Frame: 24 hours
Asked about possible complications
24 hours
motor block success rate
Time Frame: Assessed 40 minutes after block completion
Success is defined as complete motor block in the distribution of the radial, median, ulnar, musculocutaneous nerves of the forearm and hand
Assessed 40 minutes after block completion
Success Rate of the sensorial Block
Time Frame: Assessed 30 minutes after block completion
Success is defined as complete sensory loss in the distribution of the radial, median, ulnar, musculocutaneous, and medial cutaneous nerves of the forearm and hand
Assessed 30 minutes after block completion
Block performance related pain
Time Frame: 10 minutes after the needle inserted the skin
Block performance related pain was evaluated with a visual analog scala after the removal of the needle.
10 minutes after the needle inserted the skin

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nilgun Kavrut Ozturk, MD, Antalya Training and Research Hospital
  • Principal Investigator: Ali Sait Kavakli, MD, Antalya Training and Research Hospital
  • Study Director: Hayri Fatih Metinyurt, MD, Antalya Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

April 1, 2017

Study Completion (Actual)

April 1, 2017

Study Registration Dates

First Submitted

June 12, 2017

First Submitted That Met QC Criteria

June 15, 2017

First Posted (Actual)

June 19, 2017

Study Record Updates

Last Update Posted (Actual)

June 19, 2017

Last Update Submitted That Met QC Criteria

June 15, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disorder of Upper Extremity

Clinical Trials on retroclavicular approach

3
Subscribe